SwRI’S VIRTUAL SCREENING SOFTWARE RHODIUM INCREASES PROCESSING POWER FOR CORONAVIRUS RESEARCH
Principal Investigator(s)
Dr. Shawn Blumberg
Collaborating Institutions
Texas Biomedical Research Institute
Funded by
SwRI internal funding
Research Start Date
Status
Active
Drug discovery software at Southwest Research Institute is expanding the capacity to virtually screen drug compounds for possible treatment of coronavirus and other infectious diseases.
SwRI’s Rhodium™ virtual screening tool recently evaluated 2 million drug compounds in a few days, hoping to identify high-probability drugs that may have efficacy against the coronavirus with minimal adverse side effects. Institute scientists initiated the molecular modeling research with SwRI internal funding.